25% reduction in area versus its initial area), "increased" (>25% increase) and "no change" (the remainder). The mean of treatment duration was 11.5{+/-}3.6 months. Three months after treatment, 18 patients (40.0%) were categorised as decreased, 25 (55.6%) as no change and two (4.4%) as increased. Twelve months after treatment, out of 42 patients available for chest radiographs, 32 patients (76.2%) were categorised as decreased, nine (21.4%) as no change and one patient (2.4%) as increased. At the last follow-up (mean follow-up 27.0{+/-}10.2 months), 37 patients (82.2%) were categorised as decreased. The majority of pulmonary tuberculomas were decreased by anti-tuberculosis treatment during and even after treatment, although a transient enlargement during the early period of treatment was observed infrequently.">

Response of pulmonary tuberculomas to anti-tuberculous treatment

Lee H.S., Oh J.Y., Lee J.H., Yoo C.G., Lee C-T., Kim Y.W., Han S.K., Shim Y-S., Yim J-J.

Source: Eur Respir J 2004; 23: 452-455
Journal Issue: March
Disease area: Respiratory infections

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lee H.S., Oh J.Y., Lee J.H., Yoo C.G., Lee C-T., Kim Y.W., Han S.K., Shim Y-S., Yim J-J.. Response of pulmonary tuberculomas to anti-tuberculous treatment. Eur Respir J 2004; 23: 452-455

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Response of pulmonary tuberculoma to anti-tuberculosis treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 521s
Year: 2003

Side-effect in the treatment of pulmonary tuberculosis by first-line drugs
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Surgical treatment of pulmonary tuberculosis
Source: Eur Respir Monogr 2013; 61: 20-36
Year: 2013


Charectristics of pulmonary cavitary lesion in patients with pulmonary TB
Source: Eur Respir J 2004; 24: Suppl. 48, 284s
Year: 2004

Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 845s
Year: 2006

Effectiveness of thoracoplasty at disseminated drug-resistant fibrous-cavernous pulmonary tuberculosis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010

The surgical treatment of pulmonary aspergillomas
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001

Surgery as a treatment for pulmonary tuberculosis
Source: Eur Respir Monogr 2018; 82: 228-233
Year: 2018


Surgical treatment of first-found destructive pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Treatment results of new cases of sputum-positive pulmonary tuberculosis with standard chemotherapeutical regimen
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Effectiveness of complex treatment of bilateral destructive pulmonary XDR-tuberculosis
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2004; 24: Suppl. 48, 199s
Year: 2004

Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2003; 22: Suppl. 45, 247s
Year: 2003

Pulmonary and cerebral miliary tuberculosis with meningitis
Source: Eur Respir J 2004; 24: Suppl. 48, 422s
Year: 2004

Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006

Atypical pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012

Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004